Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026)
Lantheus Holdings' (LNTH) quarterly Current Deferred Revenue came in at $9.4 million in Q2 2026, up 43.25% quarter-over-quarter from $6.6 million in Q1 2026.
Analysis
Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Current Deferred Revenue for 4 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $9.4 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.0 million, up 382.65% from the prior year.
- Current Deferred Revenue was $9.4 million for Q2 2026 at Lantheus Holdings, up from $6.6 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $9.4 million in Q2 2026 and troughed at $1.4 million in Q4 2024.
- A 4-year average of $5.2 million and a median of $6.6 million in 2026 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue retreated 2.82% in 2024 and jumped 382.65% in 2025, its largest moves.
- Over 4 years, Current Deferred Revenue stood at $1.5 million in 2023, then retreated by 2.82% to $1.4 million in 2024, then jumped by 382.65% to $7.0 million in 2025, then soared by 35.29% to $9.4 million in 2026.
- The last three Current Deferred Revenue figures came in at $9.4 million (Q2 2026), $6.6 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.45 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.49 Mn |